CH Biotech R&D Co., Ltd.(TW:6534)
NT$86.00+0.50 (+0.58%)
TW:6534
CH Biotech R&D Co., Ltd. financials statements
NT$86.00
At close:+0.50 (+0.58%)
CH Biotech R&D Co., Ltd. (6534) Financial Statements
CH Biotech R&D Co., Ltd. Financial Overview
CH Biotech R&D Co., Ltd.'s market cap is currently NT$8.35B. The company's EPS TTM is NT$5.91; its P/E ratio is 15.17; and it has a dividend yield of 6.17%. CH Biotech R&D Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.82B | NT$ 1.64B | NT$ 1.51B | NT$ 1.43B | NT$ 1.02B |
| Gross Profit | NT$ 1.36B | NT$ 1.36B | NT$ 1.26B | NT$ 1.13B | NT$ 847.95M |
| Operating Income | NT$ 623.13M | NT$ 542.29M | NT$ 565.86M | NT$ 582.04M | NT$ 373.44M |
| EBITDA | NT$ 837.25M | NT$ 797.71M | NT$ 761.56M | NT$ 722.29M | NT$ 470.20M |
| Net Income | NT$ 463.79M | NT$ 476.39M | NT$ 463.29M | NT$ 465.42M | NT$ 291.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 397.27M | NT$ 482.13M | NT$ 943.00M | NT$ 533.10M | NT$ 326.79M |
| Total Assets | NT$ 3.57B | NT$ 3.63B | NT$ 3.65B | NT$ 3.20B | NT$ 3.03B |
| Total Debt | NT$ 664.33M | NT$ 747.33M | NT$ 845.16M | NT$ 894.89M | NT$ 1.12B |
| Net Debt | NT$ 270.20M | NT$ 268.47M | NT$ -94.77M | NT$ 364.86M | NT$ 801.26M |
| Total Liabilities | NT$ 888.48M | NT$ 982.44M | NT$ 1.13B | NT$ 1.11B | NT$ 1.31B |
| Stockholders' Equity | NT$ 2.69B | NT$ 2.65B | NT$ 2.52B | NT$ 2.09B | NT$ 1.72B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 465.68M | NT$ -51.51M | NT$ 542.89M | NT$ 581.35M | NT$ 192.43M |
| Operating Cash Flow | NT$ 589.02M | NT$ 538.44M | NT$ 659.15M | NT$ 698.97M | NT$ 264.36M |
| Investing Cash Flow | NT$ -141.52M | NT$ -594.77M | NT$ -142.89M | NT$ -117.22M | NT$ -44.75M |
| Financing Cash Flow | NT$ -530.39M | NT$ -406.21M | NT$ -106.60M | NT$ -375.37M | NT$ -222.06M |
Currency in TWD
